Test Price
2,800 AED✅ Home Collection Available
POU1F1 Gene Pituitary Hormone Deficiency Type 1 Genetic Test in UAE | AED 2800 | DHA Licensed
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity
ISO 9001:2015 Certified Processing – Clinically validated NGS accuracy.
VIP Home Collection (8 AM – 11 PM)
Hospital-grade cold-chain phlebotomy; no clinic visit required.
Post-Test Clinical Guidance
Telephonic result interpretation by a DHA-licensed expert physician.
Direct Billing Verification
WhatsApp +971 54 548 8731 for instant insurance eligibility.
Test Overview & Methodology
This next-generation sequencing panel comprehensively screens the POU1F1 gene for pathogenic and likely-pathogenic variants associated with combined pituitary hormone deficiency type 1 (CPHD1). The assay covers all coding exons, splice sites, and select deep intronic regions to maximize variant detection.
| Feature | POU1F1 NGS (Our Test) | Sanger Sequencing (Alternative) |
|---|---|---|
| Methodology | NGS (Full Gene Coverage) | Single‑Exon Sanger |
| Variant Detection | SNVs, Indels, CNVs (99.9% sensitivity) | SNVs only (limited scope) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Regulatory Compliance | DHA & PDPL Compliant | Often non‑compliant |
| Cold‑Chain Home Collection | Included | Not available |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that POU1F1 gene testing is a cornerstone for early diagnosis of combined pituitary hormone deficiency. Sequencing results must be correlated with clinical findings, growth charts, and baseline hormonal profiles. Early detection enables timely hormone replacement, protecting neurodevelopmental potential and long-term growth.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
⚠️ Medication Safety Advisory
Do not discontinue prescribed medication (e.g., growth hormone, levothyroxine, hydrocortisone) without consulting your doctor. Abrupt cessation can provoke life-threatening adrenal crisis or severe hypoglycaemia.
🚨 Urgent Red Flags – Seek Emergency Care if Present
- Neonatal hypoglycaemia (blood glucose <2.6 mmol/L) unresponsive to feeding
- Prolonged jaundice beyond day 14 with conjugated hyperbilirubinaemia
- Unexplained hypotension, lethargy, or poor feeding suggestive of adrenal crisis
- Severe growth failure (height velocity <4 cm/year after age 3)
- Midline facial defects or micropenis with suspected hypopituitarism
Patient FAQ & Clinical Guidance
1. Why is the POU1F1 gene test important for my newborn?
This test identifies disease‑causing variants in the POU1F1 gene that lead to combined pituitary hormone deficiency, enabling immediate hormonal replacement and preventing permanent developmental delays. Early intervention is critical for normal neurodevelopment and growth.
2. How is the sample collected and what is the turnaround time?
A trained phlebotomist collects whole blood, buccal swab, or a single drop on an FTA card during a premium home visit, with cold‑chain transportation to our ISO‑certified laboratory. Results are typically ready within 3 to 4 weeks.
3. Will my insurance cover this genetic test?
We offer direct billing verification via WhatsApp for all major UAE insurers, and our team assists with pre‑authorisation based on clinical necessity and family history. Coverage varies, but we ensure maximal transparency.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Security: All genetic data is handled in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory operates under DHA Facility License No. 1143 and adheres to ISO 9001:2015 quality standards.
Clinical & Logistical Metadata
| Test Name | POU1F1 Gene (Pituitary Hormone Deficiency Type 1) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Buccal Swab, or FTA Card |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | E23.0 |
| LOINC Code | 101367-9 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians